HALO vs RVMD
Halozyme Therapeutics, Inc. - Common Stock · Revolution Medicines, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | HALO | RVMD |
|---|---|---|
| Price | $121.84 | $177.96 |
| Market Cap | $13.83B | $38.14B |
| P/E | 43.64 | — |
| P/B | 96.34 | 14.64 |
| P/S | 9.90 | — |
| ROE | 220.8% | -43.4% |
| Net Margin | 22.7% | — |
| Gross Margin | — | — |
| Revenue Growth | 37.6% | — |
| Dividend Yield | — | — |
| EPS | $2.79 | -$5.28 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.